دورية أكاديمية

DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis.

التفاصيل البيبلوغرافية
العنوان: DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis.
المؤلفون: Okondo MC; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Johnson DC; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Sridharan R; Graduate Program in Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA., Go EB; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Chui AJ; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wang MS; Graduate Program in Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA., Poplawski SE; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA., Wu W; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA., Liu Y; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA., Lai JH; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA., Sanford DG; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA., Arciprete MO; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA., Golub TR; The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA., Bachovchin WW; Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.; Arisaph Pharmaceuticals, Boston, Massachusetts, USA., Bachovchin DA; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Graduate Program in Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
المصدر: Nature chemical biology [Nat Chem Biol] 2017 Jan; Vol. 13 (1), pp. 46-53. Date of Electronic Publication: 2016 Nov 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Nature Pub. Group, [2005]-
مواضيع طبية MeSH: Boronic Acids/*pharmacology , Caspase 1/*metabolism , Dipeptidases/*antagonists & inhibitors , Dipeptides/*pharmacology , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/*antagonists & inhibitors , Leukocytes, Mononuclear/*drug effects , Macrophages/*drug effects , Pyroptosis/*drug effects , Serine Proteinase Inhibitors/*pharmacology, Animals ; Boronic Acids/chemistry ; Caspase 1/deficiency ; Cell Line ; Dipeptidases/metabolism ; Dipeptides/chemistry ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/metabolism ; Dose-Response Relationship, Drug ; Humans ; Leukocytes, Mononuclear/enzymology ; Leukocytes, Mononuclear/pathology ; Macrophages/enzymology ; Macrophages/pathology ; Mice ; Molecular Conformation ; Serine Proteinase Inhibitors/chemistry ; Structure-Activity Relationship
مستخلص: Val-boroPro (Talabostat, PT-100), a nonselective inhibitor of post-proline cleaving serine proteases, stimulates mammalian immune systems through an unknown mechanism of action. Despite this lack of mechanistic understanding, Val-boroPro has attracted substantial interest as a potential anticancer agent, reaching phase 3 trials in humans. Here we show that Val-boroPro stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. We demonstrate that the inhibition of two serine proteases, DPP8 and DPP9, activates the pro-protein form of caspase-1 independent of the inflammasome adaptor ASC. Activated pro-caspase-1 does not efficiently process itself or IL-1β but does cleave and activate gasdermin D to induce pyroptosis. Mice lacking caspase-1 do not show immune stimulation after treatment with Val-boroPro. Our data identify what is to our knowledge the first small molecule that induces pyroptosis and reveals a new checkpoint that controls the activation of the innate immune system.
References: Cell. 2015 Apr 9;161(2):205-14. (PMID: 25860605)
N Engl J Med. 2013 Jul 11;369(2):122-33. (PMID: 23724867)
Front Immunol. 2015 Aug 07;6:387. (PMID: 26300881)
Nat Immunol. 2002 Nov;3(11):991-8. (PMID: 12407406)
J Med Chem. 2013 May 9;56(9):3467-77. (PMID: 23594271)
Cell. 2014 May 22;157(5):1013-22. (PMID: 24855941)
Bioorg Med Chem Lett. 2005 Feb 1;15(3):687-91. (PMID: 15664838)
Arch Biochem Biophys. 2009 May 15;485(2):120-7. (PMID: 19268648)
Clin Exp Immunol. 2016 Jun;184(3):265-83. (PMID: 26671446)
N Engl J Med. 2012 Jun 28;366(26):2443-54. (PMID: 22658127)
Inflammation. 2016 Feb;39(1):413-24. (PMID: 26454447)
Biochim Biophys Acta. 2004 Jul 13;1679(1):18-28. (PMID: 15245913)
Cancer Res. 2004 Aug 1;64(15):5471-80. (PMID: 15289357)
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17254-9. (PMID: 25404286)
Blood. 2003 Sep 1;102(5):1641-8. (PMID: 12738665)
Nature. 2015 Oct 29;526(7575):666-71. (PMID: 26375259)
Diabetes Obes Metab. 2008 Nov;10(11):1057-61. (PMID: 18422675)
J Immunol. 2015 Aug 1;195(3):815-9. (PMID: 26109648)
Nature. 2014 Oct 9;514(7521):187-92. (PMID: 25119034)
Bioorg Med Chem Lett. 2007 Jan 15;17(2):507-10. (PMID: 17055271)
J Immunol. 2008 Jun 1;180(11):7147-57. (PMID: 18490713)
J Med Chem. 1996 May 10;39(10):2087-94. (PMID: 8642568)
J Med Chem. 2005 Jul 28;48(15):5025-37. (PMID: 16033281)
Nat Commun. 2014;5:3209. (PMID: 24492532)
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14186-91. (PMID: 15353589)
Mol Cancer Res. 2013 Dec;11(12):1487-96. (PMID: 24038034)
Diabetes. 2005 Oct;54(10):2988-94. (PMID: 16186403)
Cell Host Microbe. 2010 Dec 16;8(6):471-83. (PMID: 21147462)
Nat Biotechnol. 2016 Feb;34(2):184-91. (PMID: 26780180)
Biochem Pharmacol. 2009 Jul 15;78(2):203-10. (PMID: 19439267)
Eur J Biochem. 2000 Oct;267(20):6140-50. (PMID: 11012666)
Cell Res. 2015 Dec;25(12):1285-98. (PMID: 26611636)
J Biol Chem. 2013 May 17;288(20):13936-49. (PMID: 23519473)
FEBS J. 2015 Oct;282(19):3737-57. (PMID: 26175140)
J Biol Chem. 2006 Dec 15;281(50):38653-62. (PMID: 17040910)
Nat Methods. 2014 Aug;11(8):783-4. (PMID: 25075903)
Nat Chem Biol. 2014 Aug;10(8):656-63. (PMID: 24997602)
Science. 2013 Dec 20;342(6165):1432-3. (PMID: 24357284)
Nature. 2015 Oct 29;526(7575):660-5. (PMID: 26375003)
PLoS One. 2013;8(3):e58860. (PMID: 23554941)
Nat Rev Immunol. 2006 Oct;6(10):715-27. (PMID: 16977338)
Nature. 2015 Oct 29;526(7575):642-3. (PMID: 26375000)
Nature. 2011 Oct 16;479(7371):117-21. (PMID: 22002608)
Hepatology. 2005 Oct;42(4):935-45. (PMID: 16175601)
Basic Res Cardiol. 2013 May;108(3):350. (PMID: 23608773)
J Med Chem. 2003 Jun 19;46(13):2774-89. (PMID: 12801240)
معلومات مُعتمدة: R41 CA174008 United States CA NCI NIH HHS; T32 CA062948 United States CA NCI NIH HHS; T32 GM115327 United States GM NIGMS NIH HHS; P30 CA008748 United States CA NCI NIH HHS; R01 CA163930 United States CA NCI NIH HHS; U54 CA112962 United States CA NCI NIH HHS
المشرفين على المادة: 0 (Boronic Acids)
0 (Dipeptides)
0 (Serine Proteinase Inhibitors)
EC 3.4.13.- (Dipeptidases)
EC 3.4.14.- (DPP9 protein, human)
EC 3.4.14.- (Dipeptidyl-Peptidases and Tripeptidyl-Peptidases)
EC 3.4.14.5 (DPP8 protein, human)
EC 3.4.14.5 (dipeptidyl peptidase 8, mouse)
EC 3.4.14.5 (dipeptidyl peptidase 9, mouse)
EC 3.4.22.36 (Caspase 1)
KZ1O2SH88Z (talabostat)
تواريخ الأحداث: Date Created: 20161108 Date Completed: 20170515 Latest Revision: 20210617
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC5477230
DOI: 10.1038/nchembio.2229
PMID: 27820798
قاعدة البيانات: MEDLINE
الوصف
تدمد:1552-4469
DOI:10.1038/nchembio.2229